SynAct Pharma: Another SEK18m from Warrant Conversion - Redeye
Bildkälla: Stockfoto

SynAct Pharma: Another SEK18m from Warrant Conversion - Redeye

Redeye is optimistic about the second warrant conversion from HCM. This further improves SynAct's cash position with limited dilution.

Börsvärldens nyhetsbrev